Baker Tilly Wealth Management, LLC Amgen Inc Transaction History

Baker Tilly Wealth Management, LLC

$273 Million
Q2 2025

A detailed history of Baker Tilly Wealth Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Baker Tilly Wealth Management, LLC holds 909 shares of AMGN stock, worth $273,945. This represents 0.09% of its overall portfolio holdings.

Number of Shares

909

Previous 862 5.45%

Holding current value

$273,945

Previous $268,000 5.6%

% of portfolio

0.09%

Previous 0.11%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 10, 2025	BUY	$262.28 - $309.85 $12,327 - $14,562	47 Added 5.45%	909 $253,000
Q1 2025 Apr 09, 2025	BUY	$258.59 - $327.36 $5,430 - $6,874	21 Added 2.5%	862 $268,000
Q4 2024 Jan 10, 2025	BUY	$258.78 - $328.31 $1,035 - $1,313	4 Added 0.48%	841 $219,000
Q3 2024 Oct 24, 2024	SELL	$309.38 - $337.38 $206,356 - $225,032	-667 Reduced 44.35%	837 $269,000
Q2 2024 Jul 18, 2024	SELL	$262.75 - $319.31 $378,885 - $460,445	-1,442 Reduced 48.95%	1,504 $469,000
Q1 2024 May 09, 2024	BUY	$268.87 - $324.56 $11,830 - $14,280	44 Added 1.52%	2,946 $837,000
Q4 2023 Jan 10, 2024	SELL	$255.7 - $288.46 $27,359 - $30,865	-107 Reduced 3.56%	2,902 $835,000
Q3 2023 Oct 10, 2023	SELL	$218.65 - $271.46 $324,039 - $402,303	-1,482 Reduced 33.0%	3,009 $808,000
Q2 2023 Jul 20, 2023	SELL	$214.27 - $253.37 $49,282 - $58,275	-230 Reduced 4.87%	4,491 $997,000
Q1 2023 Apr 12, 2023	SELL	$225.79 - $275.2 $311,815 - $380,051	-1,381 Reduced 22.63%	4,721 $1.14 Million
Q4 2022 Jan 26, 2023	BUY	$229.03 - $291.01 $5,038 - $6,402	22 Added 0.36%	6,102 $0
Q3 2022 Oct 20, 2022	SELL	$224.46 - $253.15 $6,958 - $7,847	-31 Reduced 0.51%	6,080 $1.37 Million
Q2 2022 Jul 28, 2022	SELL	$230.71 - $256.74 $34,837 - $38,767	-151 Reduced 2.41%	6,111 $1.49 Million
Q1 2022 Apr 27, 2022	BUY	$219.27 - $242.57 $75,867 - $83,929	346 Added 5.85%	6,262 $1.51 Million
Q4 2021 Feb 08, 2022	SELL	$198.88 - $227.6 $85,518 - $97,868	-430 Reduced 6.78%	5,916 $1.33 Million
Q3 2021 Nov 02, 2021	BUY	$212.27 - $248.7 $71,110 - $83,314	335 Added 5.57%	6,346 $1.35 Million
Q2 2021 Jul 30, 2021	BUY	$233.58 - $259.14 $7,708 - $8,551	33 Added 0.55%	6,011 $1.47 Million
Q1 2021 Apr 28, 2021	BUY	$221.91 - $258.6 $440,047 - $512,803	1,983 Added 49.64%	5,978 $1.49 Million
Q4 2020 Feb 03, 2021	BUY	$216.38 - $257.67 $864,438 - $1.03 Million	3,995 New	3,995 $919,000

Others Institutions Holding AMGN

# of Institutions

3,284

Shares Held

426M

Call Options Held

7.45M

Put Options Held

7.46M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $161B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baker Tilly Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baker Tilly Wealth Management, LLC with notifications on news.

Account

Baker Tilly Wealth Management, LLC Amgen Inc Transaction History